Active Ingredient
(in each extended-release tablet)
Guaifenesin, USP
The following Structured Product Label (SPL) was submitted to the FDA by Ohm Laboratories, Inc. for the product Guaifenesin (NDC 51660-566). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, keep out of reach of children, uses, warnings, directions, inactive ingredients, questions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
(in each extended-release tablet)
Guaifenesin, USP
Expectorant
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
Do not use
Ask a doctor before use if you have
Stop use and ask a doctor if
If pregnant or breast-feeding, ask a health professional before use.
Other information
Keep the carton. It contains important information. See end panel for expiration date.
†Ohm® is a registered trademark of Sun Pharmaceutical Industries, Inc. All other trademarks are property of their respective owners.
colloidal silicon dioxide, FD&C blue # 2, aluminum lake, hypromellose, magnesium stearate, povidone.
call toll-free Monday to Friday 8:30 am to 5:00 pm EST at 1-800-406-7984.
* Please review the disclaimer below.